Cercar

13/08/2024 Personalized Medicine in Acromegaly: The ACROFAST Study
Marques-Pamies, M, Gil, J, Sampedro-Nuñez, M, Valassi, E, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Personalized Medicine in Acromegaly: The ACROFAST Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2024; 110(1)DOI:10.1210/clinem/dgae444. PMID:38943661. IF:5.100(Q1/2D).
01/08/2024 Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders
Liu, JM, Xie, XL, García-Patterson, A, Asla, Q, Sardà, H, Chico, A, Adelantado, JM, Urgell, E, Corcoy, R. Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders. ARCHIVES OF GYNECOLOGY AND OBSTETRICS. 2024; 310(2)DOI:10.1007/s00404-023-07279-z. PMID:37981602. IF:2.500(Q2/3D).
17/07/2024 Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing's syndrome: a pilot study
Seco-Cervera, M, Ibáñez-Cabellos, JS, Pallardo, FV, García-Giménez, JL, Aulinas, A, Martel-Duguech, L, Webb, SM, Valassi, E. Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing's syndrome: a pilot study. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1410080. PMID:39086897. IF:4.600(Q1/3D).
01/07/2024 Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Pérez, F, Vicente, A, Hualpa, JCP, García-Centeno, R, González-Fernández, L, García, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jiménez, C, Galiana, PA, Venegas, E, González-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Córdova, JM, Avilés-Pérez, MD, Asensio-Wandosell, D, Sampedro-Núñez, M, Cámara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs. ENDOCRINE-RELATED CANCER. 2024; 31(7)DOI:10.1530/ERC-24-0043. PMID:38713182. IF:4.600(Q1/3D).